Biomarker and Diagnostics Strategy

This is where precision medicine starts – whether you’re trying to find the right tools to uncover new biomarkers, identify CDx partners, launch an IVD, or understand how your assay will fit into the clinical journey, DeciBio has you covered. Nobody knows biomarkers and CDx better than DeciBio.

Our Experts

Andrew Aijian

Stephane Budel

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Pharma & Biotech

Global Companion Diagnostic Guideline Mapping and Strategy

A large pharma new to precision oncology wanted to understand the processes and requirements to ensure that their novel CDx was included into diagnostic guidelines globally

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

Voice-of-Customer Research

Pre-due Diligence Research on a Potential Acquisition Target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Due Diligence

Target Identification

Sequencing Technology Go-to-Market Strategy

A research tools start-up enlisted DeciBio to support their go-to-market strategy and activities for their novel sequencing technology by conducting pricing voice-of-customer research and evaluating potential pricing strategies

Voice-of-Customer Research

Go-to-Market Strategy

Pricing Strategy

Competitive Analysis

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

Voice-of-Customer Research

Pricing Strategy

Competitive Analysis

Pharma & Biotech

Biopharma Genomic Testing Market Research

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx

Voice-of-Customer Research

Precision Medicine is evolving at a rapid pace

Discover how we can help